Cell Growth & Differentiation, Vol 5, Issue 9 983-993, Copyright © 1994 by American Association of Cancer Research

ARTICLES

The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells

C Demarcq, RT Bunch, D Creswell and A Eastman
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755.

Many anticancer drugs arrest cells in G2 of the cell cycle and subsequently induce cell death by apoptosis. The current experiments establish a detailed sequence of events that occur in Chinese hamster ovary CHO/UV41 cells following incubation with cisplatin. Synchronized CHO/UV41 cells were damaged with cisplatin in early S. The cells progressed at a normal rate through S but arrested in G2. The arrested cells exhibited normal levels of the mitosis-promoting kinase p34cdc2 in its fully phosphorylated, inactive form. After a protracted arrest, the cells dephosphorylated p34cdc2 and underwent an aberrant mitosis and cytokinesis in which the chromosomes segregated unequally due to the formation of multipolar mitotic spindles. These cells subsequently lost contact with the extracellular matrix, and only then digested their DNA in a manner characteristic of apoptosis. This sequence of events could be dramatically accelerated by the addition of caffeine to G2-arrested cells, which induced dephosphorylation of p34cdc2 and passage through an aberrant mitosis. It has previously been suggested that protein synthesis is required for both caffeine-induced premature mitosis and apoptosis. However, when added in G2, cycloheximide could inhibit neither the caffeine-induced mitosis nor apoptosis. Inhibition was only seen if cycloheximide was added during S before complete synthesis of the proteins required for mitosis. These results demonstrate that, in this model, the proteins thought to be involved in apoptosis are those required for normal cell cycle progression. It is hypothesized that the DNA digestion results from loss of signal transduction originating from the extracellular matrix but that earlier events leading to loss of cell adhesion are critical for the induction of apoptosis.

This article has been cited by other articles:

				C. Peklak-Scott, P. K. Smitherman, A. J. Townsend, and C. S. Morrow Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin Mol. Cancer Ther., October 1, 2008; 7(10): 3247 - 3255. [Abstract] [Full Text] [PDF]

				A. A. Levesque, A. A. Fanous, A. Poh, and A. Eastman Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest Mol. Cancer Ther., February 1, 2008; 7(2): 252 - 262. [Abstract] [Full Text] [PDF]

				A. A. Levesque and A. Eastman p53-based cancer therapies: is defective p53 the Achilles heel of the tumor? Carcinogenesis, January 1, 2007; 28(1): 13 - 20. [Abstract] [Full Text] [PDF]

				D. Hagrman, J. Goodisman, J. C. Dabrowiak, and A.-K. Souid KINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEIN Drug Metab. Dispos., July 1, 2003; 31(7): 916 - 923. [Abstract] [Full Text] [PDF]

				E. A. Kohn, C. J. Yoo, and A. Eastman The Protein Kinase C Inhibitor Go6976 Is a Potent Inhibitor of DNA Damage-induced S and G2 Cell Cycle Checkpoints Cancer Res., January 1, 2003; 63(1): 31 - 35. [Abstract] [Full Text] [PDF]

				J. C. Dabrowiak, J. Goodisman, and A.-K. Souid Kinetic Study of the Reaction of Cisplatin with Thiols Drug Metab. Dispos., December 1, 2002; 30(12): 1378 - 1384. [Abstract] [Full Text] [PDF]

				A. Eastman, E. A. Kohn, M. K. Brown, J. Rathman, M. Livingstone, D. H. Blank, and G. W. Gribble A Novel Indolocarbazole, ICP-1, Abrogates DNA Damage-induced Cell Cycle Arrest and Enhances Cytotoxicity: Similarities and Differences to the Cell Cycle Checkpoint Abrogator UCN-01 Mol. Cancer Ther., October 1, 2002; 1(12): 1067 - 1078. [Abstract] [Full Text] [PDF]

				E. A. Kohn, N. D. Ruth, M. K. Brown, M. Livingstone, and A. Eastman Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C Activation J. Biol. Chem., July 12, 2002; 277(29): 26553 - 26564. [Abstract] [Full Text] [PDF]

				E. Papouli, M. Defais, and F. Larminat Overexpression of Metallothionein-II Sensitizes Rodent Cells to Apoptosis Induced by DNA Cross-linking Agent through Inhibition of NF-kappa B Activation J. Biol. Chem., February 8, 2002; 277(7): 4764 - 4769. [Abstract] [Full Text] [PDF]

				P. D. Sadowitz, B. A. Hubbard, J. C. Dabrowiak, J. Goodisman, K. A. Tacka, M. K. Aktas, M. J. Cunningham, R. L. Dubowy, and A.-K. Souid Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs Drug Metab. Dispos., February 1, 2002; 30(2): 183 - 190. [Abstract] [Full Text] [PDF]

				M. A. Shah and G. K. Schwartz Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181. [Abstract] [Full Text] [PDF]

				R. J. Sleiman and B. W. Stewart Early Caspase Activation in Leukemic Cells Subject to Etoposide-induced G2-M Arrest: Evidence of Commitment to Apoptosis Rather Than Mitotic Cell Death Clin. Cancer Res., September 1, 2000; 6(9): 3756 - 3765. [Abstract] [Full Text]

				I. Petak, D. M. Tillman, F. G. Harwood, R. Mihalik, and J. A. Houghton Fas-dependent and -independent Mechanisms of Cell Death following DNA Damage in Human Colon Carcinoma Cells Cancer Res., May 1, 2000; 60(10): 2643 - 2650. [Abstract] [Full Text]

				J. R. Jackson, A. Gilmartin, C. Imburgia, J. D. Winkler, L. A. Marshall, and A. Roshak An Indolocarbazole Inhibitor of Human Checkpoint Kinase (Chk1) Abrogates Cell Cycle Arrest Caused by DNA Damage Cancer Res., February 1, 2000; 60(3): 566 - 572. [Abstract] [Full Text]

				R. JORQUERA and R. M. TANGUAY Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis FASEB J, December 1, 1999; 13(15): 2284 - 2298. [Abstract] [Full Text]

				B.-D. Chang, E. V. Broude, M. Dokmanovic, H. Zhu, A. Ruth, Y. Xuan, E. S. Kandel, E. Lausch, K. Christov, and I. B. Roninson A Senescence-like Phenotype Distinguishes Tumor Cells That Undergo Terminal Proliferation Arrest after Exposure to Anticancer Agents Cancer Res., August 1, 1999; 59(15): 3761 - 3767. [Abstract] [Full Text] [PDF]

				J. MARTÍNEZ-BOTAS, Y. SUÁREZ, A. J. FERRUELO, D. GÓMEZ-CORONADO, and M. A. LASUNCIÓN Cholesterol starvation decreases P34cdc2 kinase activity and arrests the cell cycle at G2 FASEB J, August 1, 1999; 13(11): 1359 - 1370. [Abstract] [Full Text]

				P. A. Johnson, P. Clements, K. Hudson, and K. W. Caldecott A Mitotic Spindle Requirement for DNA Damage-induced Apoptosis in Chinese Hamster Ovary Cells Cancer Res., June 1, 1999; 59(11): 2696 - 2700. [Abstract] [Full Text] [PDF]

				G. S. Hagopian, G. B. Mills, A. R. Khokhar, R. C. Bast Jr., and Z. H. Siddik Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the Novel Platinum Analogue (1R, 2R-Diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV) Clin. Cancer Res., March 1, 1999; 5(3): 655 - 663. [Abstract] [Full Text] [PDF]

				L. Yu, L. Orlandi, P. Wang, M. S. Orr, A. M. Senderowicz, E. A. Sausville, R. Silvestrini, N. Watanabe, H. Piwnica-Worms, and P. M. O'Connor UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase J. Biol. Chem., December 11, 1998; 273(50): 33455 - 33464. [Abstract] [Full Text] [PDF]

				D. B. Zamble, T. Jacks, and S. J. Lippard p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells PNAS, May 26, 1998; 95(11): 6163 - 6168. [Abstract] [Full Text] [PDF]

				J. J. Turchi and K. Henkels Human Ku Autoantigen Binds Cisplatin-damaged DNA but Fails to Stimulate Human DNA-activated Protein Kinase J. Biol. Chem., June 7, 1996; 271(23): 13861 - 13867. [Abstract] [Full Text] [PDF]

				S. Rehen, M. Varella, F. Freitas, M. Moraes, and R Linden Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina Development, January 5, 1996; 122(5): 1439 - 1448. [Abstract] [PDF]